Results 171 to 180 of about 168,114 (189)

Treatment of MOG-IgG associated disease in paediatric patients: A systematic review

Multiple Sclerosis and Related Disorders, 2021
Aim to perform a systematic review of the literature on treatment of paediatric patients with MOG-IgG associated disease (MOGAD). Method We followed the guidelines of the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) statement. The search was conducted in Pubmed (MEDLINE) seeking articles of treatment of MOGAD in patients ≤
Bruna, Klein da Costa, Brenda Louise, Banwell, Douglas Kazutoshi, Sato   +2 more
openaire   +2 more sources

Is MOG-IgG another biomarker for neuromyelitis optica?

Journal of Neurology, Neurosurgery & Psychiatry, 2017
Myelin oligodendrocyte glycoprotein (MOG) is a glycoprotein exclusively expressed on the surface of the myelin sheath in the central nervous system (CNS). Although the precise function of MOG is yet unknown, it is possibly related to the maintenance of the myelin structure.
openaire   +2 more sources

SEIZURES AND CORTICAL LESIONS IN MOG IgG ASSOCIATED SYNDROMES

Journal of Neurology, Neurosurgery & Psychiatry, 2016
Background Antibodies to myelin oligodendrocyte glycoprotein (MOG) are being increasingly detected in patients with non-MS demyelination many of whom have the neuromyelitis optica spectrum disorders (NMOSD) phenotype. Cortical involvement or seizures are rare in AQP4 IgG NMO.
Shahd Hamid, Mariyam Saviour, Kerry Much, Liene Elsone, Maneesh Bhojak, Anu Jacob   +5 more
openaire   +1 more source

Reader response: A multicenter comparison of MOG-IgG cell-based assays

Neurology, 2020
I read with interest the article by Waters et al.1 In this much-needed case-control study, the authors determined high specificity of cell-based assays (CBAs) for myelin oligodendrocyte glycoprotein immunoglobulin G (MOG-IgG), although the live CBAs had even higher specificity (>99%) than the Euroimmun-fixed CBA (98%).
openaire   +2 more sources

MOG IgG Related Disorders: Different Clinical Presentations

2020
Europ Acad ...
Demir, S., Gumus, H., Sen, S., Uzunkopru, C., Togrol, R. E., Beckmann, Y., Terzi, M.   +6 more
openaire   +1 more source

MOG-IgG in neuromyelitis optica

Journal of Neurology, 2014
Sebastian, Luppe, Neil P, Robertson
openaire   +2 more sources

Age-Related Clinical Presentation of MOG-IgG Seropositivity in Israel

Frontiers in Neurology, 2021
Adi Vaknin Dembinsky, Netaniel Rein, Shira Rabinowicz   +2 more
exaly  

MOG-IgG-assoziierte Erkrankung

InFo Neurologie + Psychiatrie
Ilya Ayzenberg, Carolin Schwake
openaire   +1 more source

Coexisting systemic and organ-specific autoimmunity in MOG-IgG1-associated disorders versus AQP4-IgG+ NMOSD

Multiple Sclerosis Journal, 2021
Brian Weinshenker, Andrew McKeon, Melissa Snyder   +2 more
exaly  

MOG-IGG status in people with multiple sclerosis

Journal of the Neurological Sciences
Jae-Won Hyun, Jieun Chung, Rosah May Palermo Payumo, Na Young Park, You-Ri Kang, Su-Hyun Kim, Ho Jin Kim   +6 more
openaire   +1 more source